These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2144315)

  • 1. Treatment of panic and agoraphobia. An integrative review.
    Mattick RP; Andrews G; Hadzi-Pavlovic D; Christensen H
    J Nerv Ment Dis; 1990 Sep; 178(9):567-76. PubMed ID: 2144315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioural and combined therapy in panic states.
    Pecknold JC
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):97-104. PubMed ID: 2888162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential combination of imipramine and self-directed exposure in the treatment of panic disorder with agoraphobia.
    Mavissakalian M
    J Clin Psychiatry; 1990 May; 51(5):184-8. PubMed ID: 2335493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Panic and avoidance in agoraphobia. Application of path analysis to treatment studies.
    Klein DF; Ross DC; Cohen P
    Arch Gen Psychiatry; 1987 Apr; 44(4):377-85. PubMed ID: 2882736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agoraphobia: relative and combined effectiveness of therapist-assisted in vivo exposure and imipramine.
    Mavissakalian M; Michelson L
    J Clin Psychiatry; 1986 Mar; 47(3):117-22. PubMed ID: 3512534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine.
    Schweizer E; Rickels K; Weiss S; Zavodnick S
    Arch Gen Psychiatry; 1993 Jan; 50(1):51-60. PubMed ID: 8422222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial.
    Taylor CB; Hayward C; King R; Ehlers A; Margraf J; Maddock R; Clark D; Roth WT; Agras WS
    J Clin Psychopharmacol; 1990 Apr; 10(2):112-8. PubMed ID: 2187912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.
    Charney DS; Woods SW; Goodman WK; Rifkin B; Kinch M; Aiken B; Quadrino LM; Heninger GR
    J Clin Psychiatry; 1986 Dec; 47(12):580-6. PubMed ID: 3536889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A meta-analysis of treatments for panic disorder with agoraphobia: imipramine, alprazolam, and in vivo exposure.
    Cox BJ; Endler NS; Lee PS; Swinson RP
    J Behav Ther Exp Psychiatry; 1992 Sep; 23(3):175-82. PubMed ID: 1487535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of the Cross-National Collaborative Panic Study.
    Klerman GL
    Arch Gen Psychiatry; 1988 May; 45(5):407-12. PubMed ID: 3282477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of panic, anticipatory anxiety, agoraphobia and global improvement in panic disorder with agoraphobia treated with alprazolam and exposure.
    Başoğlu M; Marks IM; Kiliç C; Swinson RP; Noshirvani H; Kuch K; O'Sullivan G
    Br J Psychiatry; 1994 May; 164(5):647-52. PubMed ID: 7921715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and medication outcome after short-term alprazolam and behavioral group treatment in panic disorder. 2.5 year naturalistic follow-up study.
    Nagy LM; Krystal JH; Woods SW; Charney DS
    Arch Gen Psychiatry; 1989 Nov; 46(11):993-9. PubMed ID: 2818144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imipramine dose-response relationship in panic disorder with agoraphobia. Preliminary findings.
    Mavissakalian MR; Perel JM
    Arch Gen Psychiatry; 1989 Feb; 46(2):127-31. PubMed ID: 2643933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of alprazolam and imipramine in the treatment of agoraphobia and panic disorder.
    Rizley R; Kahn RJ; McNair DM; Frankenthaler LM
    Psychopharmacol Bull; 1986; 22(1):167-72. PubMed ID: 2873609
    [No Abstract]   [Full Text] [Related]  

  • 15. Follow-up on the treatment of panic disorder with or without agoraphobia: a quantitative review.
    Bakker A; van Balkom AJ; Spinhoven P; Blaauw BM; van Dyck R
    J Nerv Ment Dis; 1998 Jul; 186(7):414-9. PubMed ID: 9680042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of panic disorder with agoraphobia: randomized placebo-controlled trial of four psychosocial treatments combined with imipramine or placebo.
    Marchand A; Coutu MF; Dupuis G; Fleet R; Borgeat F; Todorov C; Mainguy N
    Cogn Behav Ther; 2008; 37(3):146-59. PubMed ID: 18608313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto.
    Marks IM; Swinson RP; Başoğlu M; Kuch K; Noshirvani H; O'Sullivan G; Lelliott PT; Kirby M; McNamee G; Sengun S
    Br J Psychiatry; 1993 Jun; 162():776-87. PubMed ID: 8101126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The structure of phobias in panic disorder.
    Argyle N; Solyom C; Solyom L
    Br J Psychiatry; 1991 Sep; 159():378-82. PubMed ID: 1958949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological response to stress in agoraphobia and panic attacks.
    Surman OS; Williams J; Sheehan DV; Strom TB; Jones KJ; Coleman J
    Biol Psychiatry; 1986 Jul; 21(8-9):768-74. PubMed ID: 3524696
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.